Drug Shortage Report for CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE

Last updated on 2026-01-20

Report ID 275298
Drug Identification Number 02408813
Brand name CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
Common or Proper name CISATRACURIUM BESYLATE INJECTION
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) CISATRACURIUM
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 10 mL vial / fiole
ATC code M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2026-01-06
Estimated end date 2026-01-26
Actual end date
Shortage status Actual shortage
Updated date 2026-01-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2026-01-20 French Compare
v8 2026-01-20 English Compare
v7 2026-01-14 French Compare
v6 2026-01-14 English Compare
v5 2026-01-13 French Compare
v4 2026-01-13 English Compare
v3 2026-01-08 English Compare
v2 2026-01-06 French Compare
v1 2026-01-06 English Compare

Showing 1 to 9 of 9